日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial

Evolocumab 可降低无已知显著动脉粥样硬化且患有糖尿病的患者首次发生重大心血管事件的风险：VESALIUS-CV 试验结果

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2026.3277
Marston, Nicholas A; Bohula, Erin A; Bhatia, Ajay K; De Ferrari, Gaetano M; Leiter, Lawrence A; Nicolau, Jose C; Park, Jeong-Gun; Murphy, Sabina A; Walsh, Emileigh; Liu, Lyrica; Verma, Subodh; Sattar, Naveed; Nicholls, Stephen J; Lopez-Sendon, Jose; Gouni-Berthold, Ioanna; Tokgozoglu, Lale; Blankstein, Ron; Cyrille, Marcoli; da Silva Lima, Gabriel Paiva; Giugliano, Robert P; Sabatine, Marc S
糖尿病
心血管
动脉粥样硬化
代谢
发表日期：2026
文献求助 收藏

Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation: A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 Trial

阿贝拉西单抗与利伐沙班治疗老年房颤患者：AZALEA-TIMI 71 2b 期试验的预设分析

期刊:Jama Cardiology
影响因子:14.1
doi:10.1001/jamacardio.2025.5418
Al Said, Samer; Patel, Siddharth M; Giugliano, Robert P; Morrow, David A; Goodrich, Erica L; Murphy, Sabina A; Hug, Bruce; Parkar, Sanobar; Chen, Shih-Ann; Goodman, Shaun G; Joung, Boyoung; Kiss, Robert G; Wojakowski, Wojciech; Weitz, Jeffrey I; Bloomfield, Dan; Sabatine, Marc S; Ruff, Christian T
TIM
发表日期：2026
文献求助 收藏

Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial

阿贝拉西单抗与利伐沙班治疗接受抗血小板治疗的房颤患者：AZALEA-TIMI 71试验的预设分析

期刊:Circulation
影响因子:38.6
doi:10.1161/CIRCULATIONAHA.125.074037
Al Said, Samer; Patel, Siddharth M; Giugliano, Robert P; Morrow, David A; Goodrich, Erica L; Murphy, Sabina A; Hug, Bruce; Parkar, Sanobar; Chen, Shih-Ann; Goodman, Shaun G; Joung, Boyoung; Kiss, Robert G; Wojakowski, Wojciech; Weitz, Jeffrey I; Bloomfield, Dan; Sabatine, Marc S; Ruff, Christian T
血小板
TIM
发表日期：2025
文献求助 收藏

Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial

使用依洛尤单抗强化降低自身免疫性或炎症性疾病患者的低密度脂蛋白胆固醇水平：FOURIER试验分析

期刊:Circulation
影响因子:38.6
doi:10.1161/CIRCULATIONAHA.124.072756
Zimerman, Andre; Kunzler, Ana Laura F; Weber, Brittany N; Ran, Xinhui; Murphy, Sabina A; Wang, Huei; Honarpour, Narimon; Keech, Anthony C; Sever, Peter S; Sabatine, Marc S; Giugliano, Robert P
免疫/内分泌
炎症/感染
炎症
代谢
发表日期：2025
文献求助 收藏

Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71

长效因子XI抑制剂与围手术期出血：来自AZALEA-TIMI 71研究的分析

期刊:Journal of the American College of Cardiology
影响因子:22.3
doi:10.1016/j.jacc.2025.04.018
Patel, Siddharth M; Giugliano, Robert P; Morrow, David A; Parkar, Sanobar; Shapiro, Hannah; Hug, Bruce; Kuder, Julia F; Goodrich, Erica L; Chen, Shih-Ann; Goodman, Shaun G; Joung, Boyoung; Kiss, Robert G; Wojakowski, Wojciech; Weitz, Jeffrey I; Murphy, Sabina A; Wiviott, Stephen D; Bloomfield, Daniel; Sabatine, Marc S; Ruff, Christian T
TIM
发表日期：2025
文献求助 收藏

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial

肾功能对使用阿贝拉西单抗抑制因子XI治疗房颤的安全性影响：AZALEA-TIMI 71随机临床试验的预设分析

期刊:Jama Cardiology
影响因子:14.1
doi:10.1001/jamacardio.2025.3393
Patel, Siddharth M; Giugliano, Robert P; Morrow, David A; Goodrich, Erica L; Murphy, Sabina A; Hug, Bruce; Parkar, Sanobar; Chen, Shih-Ann; Goodman, Shaun G; Joung, Boyoung; Kiss, Robert G; Wojakowski, Wojciech; Weitz, Jeffrey I; Bloomfield, Dan; Sabatine, Marc S; Ruff, Christian T
TIM
发表日期：2025
文献求助 收藏

Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE Trial

Olpasiran、氧化磷脂和系统性炎症生物标志物：OCEAN(a)-DOSE试验的结果

期刊:Jama Cardiology
影响因子:14.1
doi:10.1001/jamacardio.2024.5433
Rosenson, Robert S; López, J Antonio G; Gaudet, Daniel; Baum, Seth J; Stout, Elmer; Lepor, Norman E; Park, Jeong-Gun; Murphy, Sabina A; Knusel, Beat; Wang, Jingying; Wilmanski, Tomaz; Wang, Huei; Wu, You; Kassahun, Helina; Sabatine, Marc S; O'Donoghue, Michelle L
炎症/感染
炎症
发表日期：2025
文献求助 收藏

Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial

抗凝治疗的房颤患者鼻出血与非鼻出血的比较：ENGAGE AF-TIMI 48 试验结果

期刊:Journal of the American Heart Association
影响因子:5.3
doi:10.1161/JAHA.123.031434
Semco, Robert S; Bergmark, Regan W; Murphy, Sabina A; Cange, Abby L; Unverdorben, Martin; Chen, Cathy Z L; Ruff, Christian T; Antman, Elliott M; Giugliano, Robert P; Bergmark, Brian A
ENG
TIM
发表日期：2025
文献求助 收藏

Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia

奥利沙坦治疗重度高甘油三酯血症患者的 CORE-TIMI 72a 和 CORE2-TIMI 72b 试验的设计和原理

期刊:American Heart Journal
影响因子:3.5
doi:10.1016/j.ahj.2025.03.003
Marston, Nicholas A; Bergmark, Brian A; Alexander, Veronica J; Karwatowska-Prokopczuk, Ewa; Kang, Yu Mi; Moura, Filipe A; Prohaska, Thomas A; Zimerman, Andre; Zhang, Shuanglu; Murphy, Sabina A; Tsimikas, Sotirios; Giugliano, Robert P; Sabatine, Marc S
TIM
发表日期：2025
文献求助 收藏

Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trial

奥拉扎森用于伴有高心血管风险的高甘油三酯血症患者：Essence-TIMI 73b试验的原理和设计

期刊:American Heart Journal
影响因子:3.5
doi:10.1016/j.ahj.2025.02.022
Bergmark, Brian A; Marston, Nicholas A; Prohaska, Thomas A; Alexander, Veronica J; Zimerman, Andre; Moura, Filipe A; Kang, Yu Mi; Murphy, Sabina A; Zhang, Shuanglu; Lu, Michael T; Karwatowska-Prokopczuk, Ewa; Tsimikas, Sotirios; Giugliano, Robert P; Sabatine, Marc S
TIM
发表日期：2025
文献求助 收藏